• linkedin
  • Increase Font
  • Sharebar

    10 More Newly Approved Drugs

    The FDA is having a productive 2017.


    Man in pain

    SYMPROIC (naldemedine), Purdue Pharma

    Indications: Treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

    Dosage: 0.2 mg once daily with or without food.

    Contraindications: Patients with known or suspected gastrointestinal obstruction or at increased risk of recurrent obstruction. Patients with a history of a hypersensitivity reaction to naldemedine.

    Read the prescribing information here

    Previous ButtonNext Button


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available